Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids

被引：97
|
作者：
Chojkier, M
机构：
[1] Vet Affairs Healthcare Syst, Dept Med, La Jolla, CA 92161 USA
[2] Vet Affairs Healthcare Syst, Ctr Mol Genet, La Jolla, CA 92161 USA
[3] Univ Calif San Diego, VAMC, La Jolla, CA 92161 USA
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 39卷 / 03期
关键词：
D O I：
10.1016/S0168-8278(03)00231-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：437 / 446
页数：10
相关论文
共 50 条
  • [31] Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome
    Xuefeng Kan
    Jin Ye
    Xinxin Rong
    Zhiwen Lu
    Xin Li
    Yong Wang
    Ling Yang
    Keshu Xu
    Yuhu Song
    Xiaohua Hou
    Scientific Reports, 6
  • [32] Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome
    Kan, Xuefeng
    Ye, Jin
    Rong, Xinxin
    Lu, Zhiwen
    Li, Xin
    Wang, Yong
    Yang, Ling
    Xu, Keshu
    Song, Yuhu
    Hou, Xiaohua
    SCIENTIFIC REPORTS, 2016, 6
  • [33] Hepatic Sinusoidal-obstruction Syndrome and Busulfan-induced Lung Injury in a Post-autologous Stem Cell Transplant Recipient
    Jain, Richa
    Gupta, Kirti
    Bhatia, Anmol
    Bansal, Arun
    Bansal, Deepak
    INDIAN PEDIATRICS, 2017, 54 (09) : 765 - 770
  • [34] Establishment and evaluation of mouse models of hepatic sinusoidal obstruction syndrome induced by three pyrrolidine alkaloids
    刘畅
    China Medical Abstracts(Internal Medicine), 2020, 37 (03) : 177 - 177
  • [35] MODEL SYSTEMS FOR DETECTING THE HEPATIC TOXICITY OF PYRROLIZIDINE ALKALOIDS AND PYRROLIZIDINE ALKALOID N-OXIDES
    MOORE, DJ
    BATTS, KP
    ZALKOW, LL
    FORTUNE, GT
    POWIS, G
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 101 (02) : 271 - 284
  • [36] TOXICITY AND METABOLISM OF PYRROLIZIDINE ALKALOIDS
    CHEEKE, PR
    JOURNAL OF ANIMAL SCIENCE, 1988, 66 (09) : 2343 - 2350
  • [37] Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome
    Gao, Hong
    Ruan, Jianqing Q.
    Chen, Jie
    Li, Na
    Ke, Changqiang Q.
    Ye, Yang
    Lin, Ge
    Wang, Jiyao Y.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 4861 - 4868
  • [38] Functional metabolomics characterizes the contribution of farnesoid X receptor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome
    Xiong, Aizhen
    Lu, Longhui
    Jiang, Kaiyuan
    Wang, Xiaoning
    Chen, Yan
    Wang, Xunjiang
    Zhang, Wei
    Zhuge, Yuzheng
    Huang, Wendong
    Li, Lujin
    Liao, Qi
    Yang, Fan
    Liu, Ping
    Ding, Lili
    Wang, Zhengtao
    Yang, Li
    ARCHIVES OF TOXICOLOGY, 2024, 98 (08) : 2557 - 2576
  • [39] Histological evaluation of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: Correlation with Drum Tower Severity Scoring
    Li, Ruiqi
    Li, Lin
    Cai, Zihao
    Chen, Jun
    Zhang, Han
    Zhao, Si
    Tu, Jingjing
    Sun, Chang
    Jin, Yani
    Zhang, Ming
    Zhang, Feng
    Zhang, Wei
    Yin, Qin
    Xu, Hui
    Han, Hao
    Li, Taishun
    Zhuge, Yuzheng
    Xiao, Jiangqiang
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (07) : 1220 - 1228
  • [40] Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome
    Wu, Fan
    Yu, Jiao
    Gan, Hongying
    Zhang, Heng
    Tian, Deying
    Zheng, Dan
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345